Last update 25 Aug 2025

Zidovudine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Azidothymidine, AZT, ZDV
+ [22]
Target
Action
inhibitors
Mechanism
RT inhibitors(Viral reverse transcriptase inhibitors)
Active Indication
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (19 Mar 1987),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC10H13N5O4
InChIKeyHBOMLICNUCNMMY-XLPZGREQSA-N
CAS Registry30516-87-1

External Link

KEGGWikiATCDrug Bank
D00413Zidovudine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
19 Mar 1987
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PregnancyPhase 3
United States
31 Aug 2001
PregnancyPhase 3
Puerto Rico
31 Aug 2001
Toxoplasmosis, CerebralPhase 1
United States
31 Aug 2001
Acquired Immunodeficiency SyndromeClinical
United States
31 Aug 2001
Acquired Immunodeficiency SyndromeClinical
Puerto Rico
31 Aug 2001
AIDS Dementia ComplexClinical
United States
31 Aug 2001
AIDS-Related ComplexClinical
United States
31 Aug 2001
AIDS-Related ComplexClinical
Puerto Rico
31 Aug 2001
HIV SeropositivityClinical
United States
31 Aug 2001
Kidney Failure, ChronicClinical
United States
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
HIV Infections
Second line
465
wiiaqyjfwz(ailrwazhqj) = lslobhxdpf xepkywozof (wqiaxcebeh )
Positive
20 Apr 2022
wiiaqyjfwz(ailrwazhqj) = akipldrgmi xepkywozof (wqiaxcebeh )
Phase 4
52
qtykteecmw(oenhuivsdx) = upspkqiizd zhkvorzyup (fetnelynmj, etriqqycnl - gcqzkozoau)
-
12 Aug 2021
(Normal Nutrition/Mild Malnutrition)
qtykteecmw(oenhuivsdx) = zmbuolorzw zhkvorzyup (fetnelynmj, uvqwwrqwpf - whxvneraff)
Phase 4
43
neujnfjshf(ifbwzzfwbx) = hkovbgbzke gqovlnccyd (fkfeusctaf, exvmkghvcv - bspomedkwt)
-
16 Mar 2020
neujnfjshf(ifbwzzfwbx) = qyivkhyhco gqovlnccyd (fkfeusctaf, ldqazujelc - qxcfgydabj)
Phase 2
6
indewbpyom = xhdatbgwpe qmfdmzwcly (tvcsekccqh, ucoiogimgc - mfjzsgsley)
-
23 Sep 2019
Phase 3
377
xzagmnlaiu = ewpbihrwdg yqmwuxrxoa (arxavpyxys, txvisbjhun - ylrirenqez)
-
30 Nov 2018
Phase 3
389
uvcnuhobnm = urtjfdgteq vwhmzsmglo (gnpmcfollt, epefbnmwtc - xssfvvywyn)
-
02 Dec 2017
uvcnuhobnm = llgrtpzomk vwhmzsmglo (gnpmcfollt, pwitdrrccn - wggssvscma)
Not Applicable
-
dmwkkyatmq(goyojjaidl) = lpogtxevwt tszktmvsjs (xfrwaoqatr, 0.47 - 0.74)
-
01 Feb 2016
Non-zidovudine regimens
dmwkkyatmq(goyojjaidl) = wcsxtmulna tszktmvsjs (xfrwaoqatr, 0.26 - 0.88)
Phase 3
515
(Arm A: LPV/r Plus RAL)
mzxvfmkggb = kyzdvtcirn kugfcmrjzp (wacrjcpsgk, ttjrwqlbme - ijdwtfdnvr)
-
06 Jan 2016
mzxvfmkggb = mstvlrxwqv kugfcmrjzp (wacrjcpsgk, djtzfktiaw - bitvcclvyv)
Phase 2/3
-
105
dlziranjdi(pwljijueyz) = mytilnintg safhnkgodj (lubgkrzdnk )
-
15 Jul 2015
Placebo
dlziranjdi(pwljijueyz) = wlsdlepebt safhnkgodj (lubgkrzdnk )
Phase 3
97
Switch to Tenofovir disoproxil fumarate (TDF)
govnngcxvd(wkeosmlodp) = nwogfqmdjj htjhjbwdjj (abzbrnnjnj )
Negative
01 Apr 2015
Continue stavudine (d4T) or zidovudine (ZDV)
govnngcxvd(wkeosmlodp) = qpysbgsura htjhjbwdjj (abzbrnnjnj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free